2019 American Transplant Congress
Panniculectomy at the Time of Living Donor Renal Transplantation: An Eight Year Experience
*Purpose: Removal of the pannus, or panniculectomy, can be performed as a prophylactic procedure preceding renal transplantation to enable obese patients to meet criteria for…2019 American Transplant Congress
A Clinical Analysis for Low-Dose Immunoglobulin United with Plasmapheresis in High Sensitization Renal Transplantation Recipients
*Purpose: To analyze the role of low-dose intravenous immunoglobulin (IVIG) united with plasmapheresis in high sensitization renal transplantation recipients.*Methods: Four patients with high levels of…2019 American Transplant Congress
Variations in Recipient and Donor Clinical Characteristics between Kidney Transplant Centers
*Purpose: When a patient can choose at which kidney transplant program to establish care, prior knowledge of program acceptance practices (of candidates and donors) can…2019 American Transplant Congress
Impact of Everolimus Therapy on HIV Persistence and Gene Expression in Transplant Patients
1UC San Francisco, San Francisco, CA, 2Case Western Reserve University, Cleveland, OH
*Purpose: mTOR is a key regulatory kinase that controls cell-cycle progression. mTOR inhibitors have been shown to reduce expression of CCR5 and promote viral transcriptional…2019 American Transplant Congress
Impact of an mHealth, Electronic Pillbox Intervention on Tacrolimus Variability in Kidney Transplantation: Results of a Prospective Randomized Clinical Trial
Medical University of South Carolina, Charleston, SC
*Purpose: Medication non-adherence (MNA) is a major risk factor and leading cause of late allograft loss in kidney transplant (KTX) recipients. Tacrolimus trough concentration variability,…2019 American Transplant Congress
Blood Profiling Reflects a Significant Down-Regulation in Oxidative Phosphorylation Following Renal Transplantation with DCD and AKI Allografts
*Purpose: The human kidney transplant (KT) patient provides a unique and compelling in situ model system to study molecular events that underlie graft recovery following…2019 American Transplant Congress
Transplantation of Kidneys from Hepatitis C Infected Donors to Hepatitis C Negative Recipients
Methodist University Hospital Transplant Institute, Memphis, TN
*Purpose: There are no data on the safety of kidney transplantation from hepatitis C (HCV) NAT positive donors to HCV naïve recipients. We report the…2019 American Transplant Congress
Robotic-Assisted versus Open- Kidney Transplantation in Non-Obese Recipients
*Purpose: Robotic Kidney Transplantation (RKT) is emerging modality of treatment for patient with end stage kidney diseases. It is accepted for obese recipients. However, there…2019 American Transplant Congress
Eculizumab Deposition in Renal Transplants
*Purpose: Eculizumab is a recombinant humanized IgG monoclonal antibody that inhibits C5, thereby preventing the activation of C5a and formation of membrane attack complex C5b-C9.…2019 American Transplant Congress
Living Donor Conversion Rates as a Quality Measure for Kidney Program Efficiency for Both New Referrals and Existing Listed Candidates
1U of Cincinnati, Cincinnati, OH, 2UC Health, Cincinnati, OH, 3U of Arkansas, Little Rock, AR
*Purpose: Arguably the most important achievement for renal failure patients is identification of a living donor (LD)and transplantation with a LD kidney. Given these considerations…
- « Previous Page
- 1
- …
- 213
- 214
- 215
- 216
- 217
- …
- 531
- Next Page »
